{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T01:00:13Z","timestamp":1709427613927},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Journal of Clinical Pathology"],"published-print":{"date-parts":[[2003,11,1]]},"DOI":"10.1309\/fngc-yemj-e3ma-e5l2","type":"journal-article","created":{"date-parts":[[2004,7,9]],"date-time":"2004-07-09T21:32:00Z","timestamp":1089408720000},"page":"754-759","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Significance of CD20 and FMC7 Expression in B-Cell Disorders"],"prefix":"10.1093","volume":"120","author":[{"given":"Julio","family":"Delgado, MD","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estella","family":"Matutes, MD, PhD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison M.","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo M.","family":"Morilla, MSc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furheen","family":"Rafiq-Mohammed, MSc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria del","family":"Giudice, MD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Catovsky, DMSc, FRCPath, FRCP, FMed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"E00001","first-page":"877","author":"Rothe, G","year":"1996","unstructured":"Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia. 1996;10:877-895.","journal-title":"Leukemia"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1136\/jcp.51.5.364","volume":"51","author":"Ginaldi","year":"1998","unstructured":"Ginaldi L, De Martinis M, Matutes E, et al. Levels of expression of CD19 and CD20 in chronic B cell leukaemias. J Clin Pathol. 1998;51:364-369.","journal-title":"J Clin Pathol"},{"key":"E00003","first-page":"57","author":"Matutes, E","year":"1994","unstructured":"Matutes E, Morilla R, Owusu-Ankomah K, et al. The immunophenotype of hairy cell leukemia (HCL): proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes. Leuk Lymphoma. 1994;14:57-61.","journal-title":"Leuk Lymphoma"},{"key":"E00004","first-page":"1640","author":"Matutes, E","year":"1994","unstructured":"Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia. 1994;8:1640-1645.","journal-title":"Leukemia"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cyto.1071","volume":"46","author":"Serke","year":"2001","unstructured":"Serke S, Schwaner I, Yordanova M, et al. Monoclonal antibody FMC7 detects a conformational epitope on the CD20 molecule: evidence from phenotyping after Rituxan therapy and transfectant cell analyses. Cytometry. 2001;46:98-104.","journal-title":"Cytometry"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1097-0320(19980415)34:2<71::AID-CYTO2>3.0.CO;2-F","volume":"34","author":"H\u00fcbl","year":"1998","unstructured":"H&uuml;bl W, Iturraspe J, Braylan RC. FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20. Cytometry. 1998;34:71-74.","journal-title":"Cytometry"},{"key":"E00007","first-page":"44","author":"D'hautcourt, JL","year":"1999","unstructured":"D'hautcourt JL, Isaac J. Mean fluorescence intensity of dual stained cells [letter]. Cytometry. 1999;38:44-45.","journal-title":"Cytometry"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/jcp.55.12.940","volume":"55","author":"Jain","year":"2002","unstructured":"Jain P, Giustolisi GM, Atkinson S, et al. Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry. J Clin Pathol. 2002;55:940-945.","journal-title":"J Clin Pathol"},{"key":"E00009","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0145-2126(88)90067-7","author":"Roxburgh, AE","year":"1988","unstructured":"Roxburgh AE. Oligosaccharide components of surface glycoproteins from leukemic lymphocytes of chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Leuk Res. 1988;12:95-102.","journal-title":"Leuk Res"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jcp.42.6.567","author":"Bennett, JM","year":"1989","unstructured":"Bennett JM, Catovsky D, Daniel MT, et al. The French-American-British (FAB) Cooperative Group. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Pathol. 1989;42:567-584.","journal-title":"J Clin Pathol"},{"key":"E00011","year":"2001","unstructured":"Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001. World Health Organization Classification of Tumours."},{"key":"E00012","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/sj.leu.2401561","volume":"13","author":"Matutes","year":"1999","unstructured":"Matutes E, Carrara P, Coignet L, et al. FISH analysis for bcl-1 rearrangements and trisomy 12 helps the diagnosis of atypical B cell leukemias. Leukemia. 1999;13:1721-1726.","journal-title":"Leukemia"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V70.5.1316.1316","author":"Loken, MR","year":"1987","unstructured":"Loken MR, Shah VO, Dattilio KL, et al. Flow cytometric analysis of human bone marrow, II: normal B-lymphocyte development. Blood. 1987;70:1316-1324.","journal-title":"Blood"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcp\/108.4.378","volume":"108","author":"Moreau","year":"1997","unstructured":"Moreau EJ, Matutes E, A'Hern RP, et al. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b). Am J Clin Pathol. 1997;108:378-382.","journal-title":"Am J Clin Pathol"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1046\/j.1468-0734.2000.00002.x","author":"Matutes, E","year":"2000","unstructured":"Matutes E, Polliack A. Morphological and immunophenotypic features of chronic lymphocytic leukemia. Rev Clin Exp Hematol. 2000;4:22-47.","journal-title":"Rev Clin Exp Hematol"},{"key":"E00016","first-page":"227","volume":"5","author":"Zola","year":"1987","unstructured":"Zola H, Neoh SH, Potter A, et al. Markers of differentiated B cell leukaemia: CD22 and FMC7 react with different molecules. Dis Markers. 1987;5:227-235.","journal-title":"Dis Markers"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1038\/sj.leu.2402584","volume":"16","author":"Sanchez","year":"2002","unstructured":"Sanchez ML, Almeida J, Vidriales B, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia. 2002;16:1460-1469.","journal-title":"Leukemia"},{"key":"E00018","first-page":"1966","volume":"10","author":"Zomas","year":"1996","unstructured":"Zomas AP, Matutes E, Morilla R, et al. Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia. 1996;10:1966-1970.","journal-title":"Leukemia"},{"key":"E00019","first-page":"413","volume":"84","author":"Cabezudo","year":"1999","unstructured":"Cabezudo E, Carrara P, Morilla R, et al. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders. Haematologica. 1999;84:413-418.","journal-title":"Haematologica"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ajh.2830400404","volume":"40","author":"Almasri","year":"1992","unstructured":"Almasri NM, Duque RE, Iturraspe J, et al. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol. 1992;40:259-263.","journal-title":"Am J Hematol"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ajcp\/106.4.457","volume":"106","author":"Tefferi","year":"1996","unstructured":"Tefferi A, Bartholmai BJ, Witzig TE, et al. Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia. Am J Clin Pathol. 1996;106:457-461.","journal-title":"Am J Clin Pathol"},{"key":"E00022","first-page":"1355","author":"Prystas, EM","year":"1993","unstructured":"Prystas EM, Parker CJ, Holguin MH, et al. Aberrant glycosylation of L-selectin on the lymphocytes of chronic lymphocytic leukemia. Leukemia. 1993;7:1355-1362.","journal-title":"Leukemia"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T18:06:33Z","timestamp":1585850793000},"score":1,"resource":{"primary":{"URL":"http:\/\/ajcp.metapress.com\/openurl.asp?genre=article&id=doi:10.1309\/FNGC-YEMJ-E3MA-E5L2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,1]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,11,1]]}},"alternative-id":["FNGCYEMJE3MAE5L2"],"URL":"https:\/\/doi.org\/10.1309\/fngc-yemj-e3ma-e5l2","relation":{},"ISSN":["0002-9173"],"issn-type":[{"value":"0002-9173","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11,1]]}}}